Aquinox Pharmaceuticals

About:

Aquinox Pharmaceuticals develops and commercializes small molecule therapeutics for the treatment of cancer and inflammatory diseases.

Website: http://www.aqxpharma.com

Twitter/X: aqxpharma

Top Investors: Cowen Group, Pfizer Venture Investments, Johnson & Johnson Development Corporation, Baker Brothers Advisors LLC, Ventures West

Description:

Aquinox Pharmaceuticals Inc., a pharmaceutical company, engages in discovery, development, and commercialization of small molecule therapeutics for the treatment of cancer and inflammatory disease. It offers AQX-MN100, a drug used to treat cancer and inflammatory disease, as well as SH2-containing inositol 5'-phosphatase inhibition program for blood cell recovery. The company was founded in 2004 and is based in Vancouver, Canada.

Total Funding Amount:

$221M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Vancouver, British Columbia, Canada

Founded Date:

2004-01-01

Contact Email:

info(AT)aqxpharma.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2016-09-20

IPO Status:

Public

Industries:

© 2025 bioDAO.ai